UBS On-Air: Paul Donovan Daily Audio 'Tariff time?'

Inside Washington DC the current focus seems to be trade tariffs, although the affordability crisis continues to be the focus in the wider economy. US President Trump suggested US consumers of imported generic pharmaceuticals would have to pay a 100% tariff from August 2027, and 200% from August 2029. The US has notably higher health care costs relative to developed European economies, and such a cost would add further to US prices.